Sidney Kimmel Comprehensive Cancer Center [clinicaltrials_resource:e4746d62acade0a72f48b8c0854a9657]
Arlene A. Forastiere, MD [clinicaltrials_resource:0056f7f489597aacbce17667c8283457]Joseph Herman, MD [clinicaltrials_resource:00bc54393f190ca56347e72f426ae5f2]George Sgouros, PhD [clinicaltrials_resource:0837141d5ec321c1c78406f1af8153ac]Harry H. Yoon, MD [clinicaltrials_resource:0990a8ec12178609475ac9853422173d]Michael B. Streiff, MD [clinicaltrials_resource:0b75270514544c8e1a15aa2bd41cbeb0]Amy DeZern, MD [clinicaltrials_resource:0dc965b1aed1bae6adffd3dda0ad89bb]Leisha A. Emens, MD, PhD [clinicaltrials_resource:0ebe028dec98db3e4cdfcff8c6330f51]Steven D. Gore, MD [clinicaltrials_resource:1007cdfa7b17479c45aad5e8bc8d7eb0]Vered Stearns, M.D. [clinicaltrials_resource:1019653858c4c8a8440c9e6edc0b8092]David M Loeb, MD, PhD [clinicaltrials_resource:10ce5d378b7265d78d3057c375795423]Vered Stearns, M.D. [clinicaltrials_resource:1334449d70e8b65d2f3a63c8ad4f63e7]Michael A Choti, M.D. [clinicaltrials_resource:15166c7323ab1ae5d12e636c34940c34]Abraham Kroon, MD, PhD [clinicaltrials_resource:1526800ff7e961797416facd992a3b32]Dung Le, MD [clinicaltrials_resource:157e373cfbb8427e54af08bd029cb145]Amy DeZern, MD [clinicaltrials_resource:15f6981d38f1c2c51379dcb5fd3a6542]Alessandro Olivi, MD [clinicaltrials_resource:19a7df71792ef96eb5520e7861ad1141]Charles M. Rudin, MD, PhD [clinicaltrials_resource:1a7c5f95e6ded4dc458fa4239b04cf4b]B. Douglas Smith, MD [clinicaltrials_resource:1a7eb1e50cc0b0fc45190cf5b493ecc7]Julie Brahmer, MD [clinicaltrials_resource:1c6655dc5718c1cc0638f745f96c979e]Nilofer Azad, MD [clinicaltrials_resource:1cd694a94b4a51acf8edc1529582f081]Dung Le, MD [clinicaltrials_resource:1fbac108f0452e8d94d9e42416fe1e8c]Jeffrey F. Geschwind, MD [clinicaltrials_resource:22c1768508d72c095bf13d87b87713ab]Sanjay Jagannath, MD [clinicaltrials_resource:24bc68724a1713a77f126ae572bc4ab7]Vered Stearns, MD [clinicaltrials_resource:256f38160a2930c9c961f06efcecbefc]Ian W. Flinn, MD, PhD [clinicaltrials_resource:290672cd83810651264afac016b59768]Allen Chen, MD, PhD [clinicaltrials_resource:2c4ce278a3e817221cd2099b212bcf47]Javier Bolanos-Meade, MD [clinicaltrials_resource:2de49ec200b49feee714fbe1e4802ae2]Dung Le, MD [clinicaltrials_resource:2f2073abaf6caeabb4c8cd8fd7d0af55]Daniel A. Laheru, MD [clinicaltrials_resource:2f8d859703e9a5d8140a158beeb3453c]Georgia B. Vogelsang, MD [clinicaltrials_resource:329c2d8a684e551509d9f844f6ce884a]Ross A. Abrams, MD [clinicaltrials_resource:34232176263be13803fce5274d8e1663]Vered Stearns, M.D. [clinicaltrials_resource:3763f80e0520b3184708ed8eec4c5e60]Nilofer Azad, MD [clinicaltrials_resource:39867b49e1869c0e3b0870c0588aca3c]Nilofer Azad, MD [clinicaltrials_resource:39f96dbebe0d8585039463cff281bda0]Karen Smith, MD, MPH [clinicaltrials_resource:3bc0332d9473e49a1f3d1ff7d55eb725]Hetty Carraway, MD [clinicaltrials_resource:3ce448862e74dfbbf364cbbdc3bb04cd]Dung Le, MD [clinicaltrials_resource:3ea5eb53eef0716ac8cb290116702be5]Javier Bolanos-Meade, MD [clinicaltrials_resource:3eb9af1abc69c93c8ee01d874d91c771]Carole Miller, MD [clinicaltrials_resource:3f85912a29ffc9e3e86c7ce191cdd744]Ephraim J. Fuchs, MD [clinicaltrials_resource:4338d7101bd9eae00765168e19e883bf]
affiliation [clinicaltrials_vocabulary:affiliation]
Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Penclomedine in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00002915]Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]UCN-01 in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003289]Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003340]Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003414]Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00003538]Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003561]Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [clinicaltrials:NCT00003572]Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma [clinicaltrials:NCT00003751]Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery [clinicaltrials:NCT00003798]Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [clinicaltrials:NCT00003802]Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003960]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003962]Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00004073]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment [clinicaltrials:NCT00005639]Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus [clinicaltrials:NCT00005878]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006239]Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00006355]Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00006452]Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00011934]MS-275 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00015925]clinicaltrials:NCT00016354Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer [clinicaltrials:NCT00022399]Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma [clinicaltrials:NCT00024466]clinicaltrials:NCT00025675UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00047242]clinicaltrials:NCT00058123clinicaltrials:NCT00068770clinicaltrials:NCT000724493-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome [clinicaltrials:NCT00077558]clinicaltrials:NCT00080626clinicaltrials:NCT00080665clinicaltrials:NCT00084383clinicaltrials:NCT00093834Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer [clinicaltrials:NCT00095589]Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas [clinicaltrials:NCT00095771]
collaborator [clinicaltrials_vocabulary:collaborator]
Combination Chemotherapy, Bone Marrow Transplantation, and Peripheral Stem Cell Transplantation in Treating Patients With Ovarian Epithelial Cancer [clinicaltrials:NCT00002600]Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Penclomedine in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00002915]Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]UCN-01 in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003289]Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003340]Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003414]Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00003538]Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003561]Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [clinicaltrials:NCT00003572]Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma [clinicaltrials:NCT00003751]Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery [clinicaltrials:NCT00003798]Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [clinicaltrials:NCT00003802]Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003960]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003962]Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00004073]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Azacitidine Plus Phenylbutyrate in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Treatment [clinicaltrials:NCT00005639]Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus [clinicaltrials:NCT00005878]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006239]Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00006355]Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00006452]Peripheral Stem Cell Transplantation Plus Chemotherapy in Treating Patients With Malignant Solid Tumors [clinicaltrials:NCT00007813]Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00011934]MS-275 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00015925]clinicaltrials:NCT00016354Celecoxib Compared With No Treatment Before Surgery in Treating Patients With Localized Prostate Cancer [clinicaltrials:NCT00022399]Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma [clinicaltrials:NCT00024466]clinicaltrials:NCT00025675UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00047242]clinicaltrials:NCT00058123clinicaltrials:NCT00068770clinicaltrials:NCT000724493-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome [clinicaltrials:NCT00077558]clinicaltrials:NCT00080626clinicaltrials:NCT00080665clinicaltrials:NCT00084383clinicaltrials:NCT00093834
lead sponsor [clinicaltrials_vocabulary:lead-sponsor]
Sargramostim Following Allogeneic Bone Marrow Transplantation in Treating Patients With Chronic Myelogenous Leukemia [clinicaltrials:NCT00002778]Penclomedine in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00002915]Combination Chemotherapy Plus Infusion of White Blood Cells in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003243]UCN-01 in Treating Patients With Advanced Cancer [clinicaltrials:NCT00003289]Cyclophosphamide Plus Topotecan in Treating Patients With Refractory or Relapsed Acute Myelogenous Leukemia [clinicaltrials:NCT00003340]Graft-Versus-Host Disease in Treating Patients With Recurrent or Refractory Lymphoma or Hodgkin's Disease [clinicaltrials:NCT00003414]Prevention of Graft-Versus-Host Disease in Patients Undergoing Bone Marrow Transplantation [clinicaltrials:NCT00003538]Interferon Alfa Plus Sargramostim in Treating Patients With Newly Diagnosed Chronic Phase Chronic Myelogenous Leukemia [clinicaltrials:NCT00003561]Total-Body Irradiation, Tacrolimus, and Mycophenolate Mofetil Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancers [clinicaltrials:NCT00003572]Penicillamine, Low Copper Diet, and Radiation Therapy in Treating Patients With Glioblastoma [clinicaltrials:NCT00003751]Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Cancer of the Pancreas That Cannot Be Removed by Surgery [clinicaltrials:NCT00003798]Pyrazoloacridine in Treating Patients With Metastatic Skin or Eye Melanoma [clinicaltrials:NCT00003802]Donor Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003960]Sargramostim After Bone Marrow Transplantation in Treating Patients With Myelodysplastic Syndrome [clinicaltrials:NCT00003961]Interleukin-2 Following Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00003962]Suramin Plus Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme [clinicaltrials:NCT00004073]Azacitidine Plus Phenylbutyrate in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome [clinicaltrials:NCT00004871]Celecoxib to Prevent Cancer in Patients With Barrett's Esophagus [clinicaltrials:NCT00005878]Cyclophosphamide Plus Bone Marrow Transplantation in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006042]Phenylbutyrate and Tretinoin in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00006239]Pyrazoloacridine Followed by Radiation Therapy in Treating Adults With Newly Diagnosed Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00006355]Gadolinium Texaphyrin Plus Radiation Therapy in Treating Patients With Supratentorial Glioblastoma Multiforme [clinicaltrials:NCT00006452]Bone Marrow Transplantation Plus Biological Therapy in Treating Patients With Chronic Myeloid Leukemia [clinicaltrials:NCT00011934]MS-275 in Treating Patients With Hematologic Cancer [clinicaltrials:NCT00015925]clinicaltrials:NCT00016354Chemotherapy, Vaccine Therapy, and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Multiple Myeloma [clinicaltrials:NCT00024466]clinicaltrials:NCT00025675UCN-01 and Irinotecan in Treating Patients With Advanced Solid Tumors [clinicaltrials:NCT00047242]clinicaltrials:NCT00058123clinicaltrials:NCT00068770clinicaltrials:NCT000724493-AP Followed By Fludarabine In Treating Patients With Relapsed or Refractory Acute or Chronic Leukemia or High-Risk Myelodysplastic Syndrome [clinicaltrials:NCT00077558]clinicaltrials:NCT00080626clinicaltrials:NCT00080665clinicaltrials:NCT00084383clinicaltrials:NCT00093834Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed Gliomas [clinicaltrials:NCT00095771]clinicaltrials:NCT00100828clinicaltrials:NCT00121173clinicaltrials:NCT00133991
source [clinicaltrials_vocabulary:source]
Sidney Kimmel Comprehensive Cancer Center [clinicaltrials_resource:e4746d62acade0a72f48b8c0854a9657]
Bio2RDF identifier
e4746d62acade0a72f48b8c0854a9657
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:e4746d62acade0a72f48b8c0854a9657
organization [clinicaltrials_vocabulary:organization]
identifier
clinicaltrials_resource:e4746d62acade0a72f48b8c0854a9657
title
Sidney Kimmel Comprehensive Cancer Center
@en
type
label
Sidney Kimmel Comprehensive Ca ...... 46d62acade0a72f48b8c0854a9657]
@en